Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir-containing regimen with low CD4 counts by Merlini, E et al.
POSTER PRESENTATION Open Access
Efficient immune reconstitution in HIV+ naïve
patients (pts) starting a first lopinavir/ritonavir-
containing regimen with low CD4 counts
E Merlini
1*, E Sinigaglia
2, G Carpani
2, T Bini
1,Ad ’Arminio Monforte
1, GC Marchetti
3
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Purpose of the study
Investigate immune restoration profile, T-cell activation
and microbial translocation in HIV+ naïve pts starting a
first LPV/r-containing regimen with low CD4.
Methods
40 HIV+ antiretroviral-naive pts starting a first tenofo-
vir/emtricitabine + LPV/r-containing ART with CD4
<350 (20 Late Presenters —LPs, CD4 <100/µL and 20
Non-Late Presenters —NLPs, CD4, 200—350/µL) were
followed for 12 months (T12). Microbial translocation
(MT) by plasma lipopolysaccharide (LPS) and sCD14
(LAL assay and ELISA), CD38+CD8, CD45R0+38+CD8,
CD127+CD4/CD8 (flow cytometry), and plasma IL-7
(ELISA) were tested at T0 and T12. T0 and T12 differ-
ences were analyzed by Mann Whitney U test.
Summary of results
At T12, all 40 HIV+ pts displayed a significant CD4 rise,
HIV viremia reduction (p=0.0006; p<0.0001, respectively)
and a decrease in activated CD38+CD8 (p<0.0001), with a
t r e n dt oa ni n c r e a s ei nC D 1 2 7 + C D 8( p = 0 . 0 7 ) .B yT 1 2 ,
both LPs and NLPs displayed a significant CD4 increase
(LPs: p=0.0001; NLPs: p=0.001), with LPs maintaining sig-
nificantly lower CD4 at T12 (p=0.0001). At T12, NLPs
and LPs displayed a significant reduction in CD38+CD8+
(p=0.009; p=0.018, respectively); only NLPs displayed a
decreasing trend in terminally-differentiated CD45R0
+CD38+CD8 (p=0.077). Compared to LPs, NLPs featured
higher CD127+CD4 proportions at all timepoints (T0,
p=0.0001; T12, p=0.001), with a significant increase in
CD127+CD8 by T12 (p=0.012), whereas no changes were
seen in LPs. NLPs also displayed a significant rise in circu-
lating IL-7 (p=0.049), whereas LPs showed a decreasing
trend (p=0.074). At T0, NLPs showed higher levels of MT
markers (LPS: p=0.01; sCD14: p=0.007). By T12, only
NLPs displayed a significant reduction in LPS (p=0.022)
and in sCD14 (p=0.005), whereas no changes were shown
in LPs.
Conclusions
In HIV+ antiretroviral-naive pts with low CD4, LPV/
r-containing regimens resulted in adequate immune
reconstitution and restoration of the IL-7/IL-7R system.
Interestingly, microbial translocation was efficiently con-
trolled only in patients with less advanced HIV infection.
However, LPV/r-based treatment resulted in a significant
reduction of peripheral T-cell activation also in patients
with late presentation. Given that T-cell activation is pre-
dictive of disease progression, our data advocate the effi-
cacy of LPV/r regimens in broad immune reconstitution
in HIV-infected pts with advanced infection.
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